Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss

Area of Science:

• Metabolic research
• Obesity research
• Gene expression analysis

Background:

• Human obesity is characterized by altered gene expression in adipose tissue.
• Leptin, PPARγ1, and 11βHSD1 levels are implicated in metabolic regulation and obesity.

Purpose of the Study:

• To investigate changes in adipose tissue gene expression of leptin, PPARγ1, and 11βHSD1 during weight loss after RYGB.
• To compare these expression levels with those in nonobese individuals.

Main Methods:

• Gene expression analysis using real-time RT-PCR in adipose tissue samples.
• Measurements taken before and at 3, 6, and 12 months post-RYGB surgery.
• Comparison between obese patients undergoing RYGB and a control group of nonobese subjects.

Main Results:

• Obese subjects exhibited higher leptin and 11βHSD1 expression and lower PPARγ1 expression compared to controls.
• Weight loss following RYGB led to decreased leptin and 11βHSD1 expression and increased PPARγ1 expression.
• By 12 months post-surgery, expression levels of these genes normalized to control levels. PPARγ2 expression remained unchanged.
• Positive correlation observed between BMI and leptin/11βHSD1 gene expression.

Conclusions:

• Obesity significantly alters adipose tissue gene expression of leptin, PPARγ1, and 11βHSD1.
• RYGB surgery effectively reverses these obesity-induced alterations in gene expression.
• Adipose tissue gene expression changes are normalized following successful weight loss induced by RYGB.